Disease-associated hepatocytes are predictive of outcomes and survival in MASLD beyond fibrosis staging. Carlessi R, Kendall TJ, Olynyk JK, Dwyer BJ, et al. Gut 2025 Sep 10:gutjnl-2025-336627. doi: 10.1136/gutjnl-2025-336627.

Read + Share

Amedeo Smart

Independent Medical Education

Carlessi R, Kendall TJ, Olynyk JK, Dwyer BJ, et al. Disease-associated hepatocytes are predictive of outcomes and survival in MASLD beyond fibrosis staging. Gut 2025 Sep 10:gutjnl-2025-336627. doi: 10.1136/gutjnl-2025-336627.
PMID: 40930580